MedTrace Logo

An Open-label, Exploratory Study to Investigate the Efficacy of BDNF Essentials® on Cognition

NCT04860778 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-28

No results posted yet for this study

Summary

The objective of this open-label, exploratory study is to investigate the efficacy of BDNF Essentials® on cognition in a healthy adult population with self-reported memory complaints. As there is a dearth of available literature on BDNF in this study population, the current study is designed to understand the role of BDNF to inform potential future studies.

Conditions

  • Cognitive Change

Interventions

DIETARY_SUPPLEMENT

BDNF Essentials

Participants will take two capsules, twice daily with water for 84 days.

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Researched Nutritionals LLC

    lead INDUSTRY

Principal Investigators

  • David Crowley, M.D. · KGK Science Inc.

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2021-09-10
Completion
2021-09-10

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04860778 on ClinicalTrials.gov